Express Scripts Holding Debt to Equity Ratio 2006-2018 | ESRX

Current and historical debt to equity ratio values for Express Scripts Holding (ESRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Express Scripts Holding debt/equity for the three months ending September 30, 2018 was 0.63.
Express Scripts Holding Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $12.97B $20.57B 0.63
2018-06-30 $13.46B $19.38B 0.70
2018-03-31 $14.90B $18.45B 0.81
2017-12-31 $14.98B $18.13B 0.83
2017-09-30 $13.73B $15.92B 0.86
2017-06-30 $13.84B $15.75B 0.88
2017-03-31 $13.91B $15.93B 0.87
2016-12-31 $14.85B $16.24B 0.91
2016-09-30 $14.93B $15.61B 0.96
2016-06-30 $11.84B $15.41B 0.77
2016-03-31 $14.38B $14.85B 0.97
2015-12-31 $13.95B $17.38B 0.80
2015-09-30 $14.04B $16.55B 0.85
2015-06-30 $14.58B $15.83B 0.92
2015-03-31 $10.74B $20.62B 0.52
2014-12-31 $10.97B $20.06B 0.55
2014-09-30 $11.44B $20.17B 0.57
2014-06-30 $12.17B $20.46B 0.60
2014-03-31 $11.15B $21.89B 0.51
2013-12-31 $12.36B $21.85B 0.57
2013-09-30 $13.48B $23.72B 0.57
2013-06-30 $13.65B $23.88B 0.57
2013-03-31 $13.82B $23.63B 0.59
2012-12-31 $14.98B $23.40B 0.64
2012-09-30 $16.15B $22.75B 0.71
2012-06-30 $16.31B $22.13B 0.74
2012-03-31 $10.54B $2.78B 3.80
2011-12-31 $7.08B $2.48B 2.86
2011-09-30 $2.99B $2.17B 1.38
2011-06-30 $3.09B $1.83B 1.69
2011-03-31 $2.49B $3.96B 0.63
2010-12-31 $2.49B $3.61B 0.69
2010-09-30 $2.49B $3.22B 0.77
2010-06-30 $2.49B $3.65B 0.68
2010-03-31 $2.49B $3.65B 0.68
2009-12-31 $2.49B $3.55B 0.70
2009-09-30 $3.47B $3.31B 1.05
2009-06-30 $3.47B $3.08B 1.13
2009-03-31 $1.16B $1.30B 0.89
2008-12-31 $1.34B $1.08B 1.24
2008-09-30 $1.52B $0.87B 1.76
2008-06-30 $1.60B $0.63B 2.55
2008-03-31 $1.68B $0.78B 2.16
2007-12-31 $1.76B $0.70B 2.53
2007-09-30 $1.74B $0.54B 3.24
2007-06-30 $1.70B $0.69B 2.47
2007-03-31 $1.16B $1.29B 0.90
2006-12-31 $1.27B $1.13B 1.13
2006-09-30 $1.48B $0.97B 1.53
2006-06-30 $1.61B $1.03B 1.55
2006-03-31 $1.36B $1.62B 0.84
2005-12-31 $1.40B $1.47B 0.96
2005-09-30 $0.35B $1.33B 0.26
2005-06-30 $0.35B $1.42B 0.25
2005-03-31 $0.36B $1.31B 0.27
Sector Industry Market Cap Revenue
Medical Medical Services $54.627B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.463B 23.39
PRA Health Sciences (PRAH) United States $6.620B 27.02
Charles River Laboratories (CRL) United States $6.310B 22.12
HealthEquity (HQY) United States $5.521B 115.57
Premier (PINC) United States $5.378B 18.33
INC Research Holdings (SYNH) United States $5.128B 20.70
Teladoc (TDOC) United States $4.102B 0.00
NovoCure (NVCR) Jersey $2.920B 0.00
AMN Healthcare Services Inc (AMN) United States $2.679B 18.38
Medpace Holdings (MEDP) United States $2.042B 25.26
BioTelemetry (BEAT) United States $2.004B 35.41
Healthways (TVTY) United States $1.482B 18.23
Intrexon (XON) United States $1.385B 0.00
IKang Healthcare (KANG) China $1.075B 53.38
CareDx (CDNA) United States $0.992B 0.00
Natera (NTRA) United States $0.986B 0.00
China Cord Blood (CO) China $0.800B 21.23
Surgery Partners (SGRY) United States $0.669B 0.00
Apollo Medical Holdings (AMEH) United States $0.600B 0.00
Establishment Labs Holdings (ESTA) $0.553B 0.00
Civitas Solutions (CIVI) United States $0.526B 10.37
OncoCyte (OCX) United States $0.074B 0.00
Interpace Diagnostics (IDXG) United States $0.042B 0.00
Cancer Genetics (CGIX) United States $0.017B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.004B 0.00